# BIO-RAD LABORATORIES, INC. (BIO) FY2026 Q2 Balance Sheet

- Company: BIO-RAD LABORATORIES, INC. (BIO)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0000012208-26-000048
- Page: https://plicit.ai/financials/bio/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/bio-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 10,252,000,000 US dollars
- **Current assets**: 3,020,500,000 US dollars
- **Non-current assets**: 7,231,500,000 US dollars
- **Liabilities**: 3,078,100,000 US dollars
- **Current liabilities**: 961,300,000 US dollars
- **Non-current liabilities**: 2,116,800,000 US dollars
- **Equity**: 7,173,900,000 US dollars
- **Short-term investments**: 1,101,500,000 US dollars
- **Inventory**: 780,600,000 US dollars
- **Cash and cash equivalents**: 517,000,000 US dollars
- **Accounts receivable, net**: 441,800,000 US dollars
- **Prepaid expenses**: 147,800,000 US dollars
- **Other current assets**: 31,800,000 US dollars
- **Other investments**: 5,723,600,000 US dollars
- **Goodwill, net**: 574,300,000 US dollars
- **Property, plant and equipment, net**: 517,900,000 US dollars
- **Purchased intangibles, net**: 160,000,000 US dollars
- **Operating lease right-of-use assets**: 154,000,000 US dollars
- **Other assets**: 101,700,000 US dollars
- **Current maturities of long-term debt and notes payable**: 400,700,000 US dollars
- **Other current liabilities**: 158,800,000 US dollars
- **Accrued payroll and employee benefits**: 150,500,000 US dollars
- **Accounts payable**: 143,500,000 US dollars
- **Income and other taxes payable**: 74,200,000 US dollars
- **Current operating lease liabilities**: 33,600,000 US dollars
- **Deferred income taxes**: 982,200,000 US dollars
- **Long-term debt, net of current maturities**: 803,000,000 US dollars
- **Other long-term liabilities**: 198,500,000 US dollars
- **Operating lease liabilities**: 133,100,000 US dollars
- **Retained earnings**: 8,020,600,000 US dollars
- **Additional paid-in capital**: 502,900,000 US dollars
- **Preferred Stock, Value, Issued**: 0 US dollars
- **Common stock - Common Class A**: 0 US dollars
- **Common stock - Common Class B**: 0 US dollars
- **Treasury stock - Treasury Stock, Common**: negative 1,078,300,000 US dollars
- **Accumulated other comprehensive loss**: negative 271,300,000 US dollars
- **Gross equity (calculated)**: 8,523,500,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.